PMC:7228307 / 573-766 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"21","span":{"begin":10,"end":14},"obj":"Gene"},{"id":"26","span":{"begin":107,"end":113},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"Gene:2213"},{"id":"A26","pred":"tao:has_database_id","subj":"26","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T5","span":{"begin":114,"end":119},"obj":"Body_part"},{"id":"T6","span":{"begin":129,"end":137},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T2","span":{"begin":107,"end":113},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T9","span":{"begin":10,"end":12},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T10","span":{"begin":114,"end":119},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4","span":{"begin":24,"end":32},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_35224"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T5","span":{"begin":114,"end":119},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"21","span":{"begin":10,"end":14},"obj":"Gene"},{"id":"26","span":{"begin":107,"end":113},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"pubann:denotes","subj":"21","obj":"Gene:2213"},{"id":"A26","pred":"pubann:denotes","subj":"26","obj":"MESH:D009369"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T5","span":{"begin":114,"end":119},"obj":"Body_part"},{"id":"T6","span":{"begin":129,"end":137},"obj":"Body_part"}],"attributes":[{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T1","span":{"begin":159,"end":171},"obj":"http://purl.obolibrary.org/obo/GO_0006909"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T1","span":{"begin":107,"end":113},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T1","span":{"begin":107,"end":113},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T1","span":{"begin":159,"end":171},"obj":"http://purl.obolibrary.org/obo/GO_0006909"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T1","span":{"begin":159,"end":171},"obj":"http://purl.obolibrary.org/obo/GO_0006909"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":107,"end":113},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"he potent FcγR‐mediated effector systems to varying degrees. This is most evident for antibodies targeting cancer cells inducing antibody‐dependent killing or phagocytosis but is also true to s"}